MICHELE JORDAN: Open Payments
NPI 1982651436 · TRUSSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,740 in 135 payments from 21 companies in 2025. Trend: 2023 $1,674 · 2024 $2,545 · 2025 $2,740
Food & beverage: $2,740
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $441 |
| ABBVIE INC. | 25 | $413 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $361 |
| Novo Nordisk Inc | 17 | $202 |
| PFIZER INC. | 10 | $175 |
| Amgen Inc. | 5 | $155 |
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $130 |
| Corcept Therapeutics | 6 | $113 |
| Corium, LLC | 5 | $84 |
Products named: REXULTI, Kerendia, UBRELVY, NURTEC ODT, CAPLYTA, REPATHA, Korlym, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
